Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

07/23/2019, Tuesday

Media Contact:
Kristy Marks
Kristy.marks@bausch.com
(908) 927-0683

Teresa Panas
teresa@tgpcomm.com
(973) 809-8590

BAUSCH + LOMB INTRODUCES FREEFLOW™ INFUSION SYSTEM FOR RETINA SURGERY

New Technology Allows for Higher Levels of Infusion Flow to Support Efficient Vitreous Removal

BRIDGEWATER, N.J., July 23, 2019 – Bausch + Lomb, a leading global eye health company, today announced the launch of the FreeFlow™ infusion system for retina surgery. The new offering allows for higher level of infusion flow compared to previous generation infusion lines to support the efficient vitreous removal provided by the company’s Bi-Blade® dual port vitrectomy cutters and Vitesse® hypersonic vitrectomy system, both designed exclusively for use with the Stellaris Elite™ vision enhancement system.

“We developed the FreeFlow infusion system to provide surgeons with great control during their high flow vitrectomy procedures,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “The FreeFlow system was specifically designed to provide surgeons with a stable surgical environment with the advent of extremely efficient vitreous removal technology across all gauges. This unique technology is the latest example of our commitment to partnering with retina specialists to deliver meaningful innovation to the operating room.”

In the FreeFlow infusion system, the infusion line goes over the top of the trocar cannula rather than inside of it, significantly increasing the size of the inner lumen and allowing surgeons to increase in-flow by 40 percent. Unlike a traditional infusion line that extends vertically off the top of the cannula, this line extends at a thirty degree angle to the cannula, providing the surgeon better access to the eye with less torqueing to direct infusion more centrally.

“The design of the FreeFlow infusion system provides steady infusion flow rates over a range of pressures,”* said Anurag Gupta, M.D., DuPage Medical Group Eye Specialists, Hinsdale, IL. “This benefit, combined with the efficiencies it offers, means that this instrument will be a welcomed addition in my procedures.”

The FreeFlow infusion system will be featured at the Bausch + Lomb booth at the American Society of Retina Specialists meeting, July 26-30, 2019 in Chicago.

*Data obtained in bench study

Please see www.bauschretina.com for Important Safety Information on the Stellaris Elite™ vision enhancement system.

About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.  

 

###

 

FreeFlow, Vitesse and Stellaris Elite are trademarks of Bausch & Lomb Incorporated or its affiliates. Bi-Blade is a trademark of Medical Instrument
Development Laboratories, Inc. used by agreement. Any other product/brand names are trademarks of the respective owners.
© 2019 Bausch & Lomb Incorporated or its affiliates.
RIN.0014.USA.19

Print

Number of views (2232)/Comments (0)

x